Cyrus J. Lawrence’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$399K Sell
803
-12,472
-94% -$6.75M 1.51% 35
2024
Q4
$6.91M Sell
13,275
-140
-1% -$77K 1.34% 32
2024
Q3
$8.3M Sell
13,415
-21
-0.2% -$12.4K 1.63% 30
2024
Q2
$7.43M Buy
13,436
+20
+0.1% +$11.5K 1.51% 31
2024
Q1
$7.8M Buy
+13,416
New +$7.53M 1.73% 29
2023
Q3
$6.96M Buy
13,758
+20
+0.1% +$10.7K 1.91% 26
2023
Q2
$7.17M Buy
13,738
+129
+0.9% +$69.6K 1.55% 24
2023
Q1
$7.84M Buy
13,609
+9
+0.1% +$5.07K 2.28% 17
2022
Q4
$7.49M Sell
13,600
-6,112
-31% -$3.24M 2.24% 21
2022
Q3
$10M Sell
19,712
-1,171
-6% -$655K 1.97% 12
2022
Q2
$11.3M Sell
20,883
-350
-2% -$193K 3.27% 7
2022
Q1
$12.5M Buy
+21,233
New +$12.2M 2.87% 9

Other funds holding TMO

Cyrus J. Lawrence's TMO Position: Q1 2025 in Review

Cyrus J. Lawrence reduced its Thermo Fisher Scientific (TMO) stake by 94% in Q1 2025, selling an estimated $6.75M and leaving 803 shares worth $399K. The position accounts for 1.51% of the portfolio, ranked #35.

Cyrus J. Lawrence first reported a position in TMO in Q1 2022 and has held it in 12 quarters since. The position peaked at $12.5M in Q1 2022. 2,577 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Cyrus J. Lawrence held 803 shares of Thermo Fisher Scientific worth $399K as of Q1 2025.
  • Cyrus J. Lawrence sold 12,472 Thermo Fisher Scientific shares in Q1 2025, an estimated $6.75M.
  • Thermo Fisher Scientific made up 1.51% of Cyrus J. Lawrence's portfolio in Q1 2025, its #35 holding.
  • Cyrus J. Lawrence first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 12 quarters since.
  • Cyrus J. Lawrence's Thermo Fisher Scientific position peaked at $12.5M in Q1 2022.
  • 2,577 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.